Pregnancy: There are limited data from the use of hyoscine butylbromide in pregnant women. Animal studies are insufficient with respect to reproductive toxicity. As a precautionary measure Hyoscine-N-butylbromide (Buscopan) is not recommended during pregnancy.
Lactation: There is insufficient information on the excretion of hyoscine butylbromide and its metabolites in human milk. A risk to the breastfeeding child cannot be excluded. Use of Buscopan during breastfeeding is not recommended.
Fertility: No studies on the effects on human fertility have been conducted.
Other Services
Country
Account